Expert Biotechnology Market Analysts Consultants

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Skilled, highly knowledgeable, and analytical professional with over fourteen years experience in the healthcare sector. Primary expertise in providing strategic insights and actionable information to life science companies. Proficient in molecular diagnostics, point of care diagnostics, genomics, immunoassays, oncology diagnostics, cardiology diagnostics, infectious disease diagnostics and personalized medicine. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations. Specialties: Extensive knowledge in the genomics, in-vitro diagnostics space. Demonstrated success in managing teams and clients, assessing business models identifying market opportunities/risks and developing strategies to optimize market penetration, competitive advantage and profit.

I'm a digital marketer who lives at the intersection of creativity and strategy. For 6+ years, I’ve been crafting campaigns that don’t just grab attention—they deliver results. From SEO that ranks to social media that connects, and ads that convert, I turn ideas into impactful outcomes. I believe in the power of data to tell stories, using tools like Zoho Analytics to uncover insights and optimize strategies that drive measurable growth. What fuels me? Turning complex challenges into seamless marketing solutions. Whether it’s designing integrated campaigns, building brands online, or diving deep into analytics, I thrive on making marketing smarter, faster, and more effective. What I Bring to the Table: Growth-focused strategies * Storytelling that sells Websites that work Insights from data Let’s transform your marketing into a growth engine—one campaign at a time.

Authentic technology recruitment leader with expertise in executive talent acquisition and building high performance recruitment teams, primarily within the tech/digital/creative disciplines.

Food Research Lab is a Global Advanced Contract Research, Development and Pilot Manufacturing Organization (CDMO) that provides solutions to the Food, Beverage, Nutraceuticals, cosmeceutical, Pet food & Agriculture sectors worldwide.

✨ Nalini bring's clarity to chaos. For the past decade, she's turned early-stage climate and ag tech ideas into market leaders—most recently taking Planet FWD from concept to Series A funded. Nalini helps technical founders translate their vision into products customers will pay for. She has led product at Fortune 500s (Bayer's Climate Corp, Corteva's Granular) and scrappy startups, and knows exactly what works at each stage. Nalini is also known to leverage the latest AI tools to help early-stage teams do more with less, teaching teams these workflows so the impact compounds. As a mother of two young kids, Nalini has established herself as a career executive who deeply cares about balancing motherhood with her career. Learn more about Nalini: LinkedIn: https://www.linkedin.com/in/nalinigupta/ Substack Newsletter: https://nalinigeorge.substack.com/

Andrea is an entrepreneur & global expert in 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲, 𝐠𝐫𝐞𝐞𝐧 𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐞𝐧𝐞𝐫𝐠𝐲 𝐭𝐫𝐚𝐧𝐬𝐢𝐭𝐢𝐨𝐧. He is the founder & "Chief Earth Officer" (i.e. a CEO on a mission for our planet) at 𝐢𝐥𝐥𝐮𝐦𝐢𝐧𝐞𝐦.𝐜𝐨𝐦, a leading sustainability information and data platform, and one of Angel List’s ‘𝐓𝐨𝐩 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞’. In 2024, illuminem achieved "the most participated round by key climate investors worldwide" and "the region's highest valuation for an early-stage climate company". Andrea is also the 𝐲𝐨𝐮𝐧𝐠𝐞𝐬𝐭 𝐩𝐫𝐨𝐟. 𝐚𝐭 𝐇𝐄𝐂 𝐏𝐚𝐫𝐢𝐬 (Europe's #1 business school), where he teaches Europe’s only Greentech course, with the goal of developing the next generation of sustainability leaders. Previous to illuminem, he served as the 𝐁𝐨𝐬𝐭𝐨𝐧 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠 𝐆𝐫𝐨𝐮𝐩’𝐬 (𝐁𝐂𝐆) 𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐫𝐞𝐞𝐧 𝐂𝐡𝐚𝐦𝐩𝐢𝐨𝐧, leading projects on sustainable investments and innovation for multinationals & governments. Andrea has been recognized by the 𝐔𝐧𝐢𝐭𝐞𝐝 𝐍𝐚𝐭𝐢𝐨𝐧𝐬 as one of the 50 𝐆𝐥𝐨𝐛𝐚𝐥 '𝐈𝐦𝐩𝐚𝐜𝐭 𝐌𝐚𝐤𝐞𝐫𝐬' ("civil society leaders making the change we need to see"), and by Startup Italia as one of '𝐈𝐭𝐚𝐥𝐲’𝐬 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬'. He is the Sustainability & Innovation 𝐂𝐨𝐥𝐮𝐦𝐧𝐢𝐬𝐭 𝐟𝐨𝐫 𝐀𝐮𝐬𝐭𝐫𝐢𝐚’𝐬 𝐦𝐚𝐢𝐧 𝐧𝐞𝐰𝐬𝐩𝐚𝐩𝐞𝐫, Der Standard; a published author in the Journal of Financial Engineering; and a speaker at events hosted by COP, Davos, and universities around the world. His latest TEDx on ESG has become “the most-watched talk in Italian on sustainability.”

Collin Hogue-Spears is the Senior Director, DTE, at Black Duck Software, leading FedRAMP authorization and federal cybersecurity compliance. He has 20+ years in technology, including Senior Program Manager for AWS GovCloud, where he protected $3B in public-sector revenue. Quoted in Politico, Dark Reading, CSO Online, and CPO Magazine on nation-state cyber operations, agentic AI security risks, and software supply chain compromise. His analysis focuses on state-sponsored supply chain campaigns and the governance gaps created by autonomous AI agents with enterprise access. He speaks intermediate Mandarin Chinese and tracks PRC cyber and AI strategy through primary-source government documents. CISSP | CISM | MBA, UMass Amherst

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Influencer | Featured on Times of India | 4x World Record Holder | 10x Microsoft & Azure Certified Expert | ITIL® 4 Specialist Certified | 44x IBM & Design Thinking Certified | SNOW | NOC/IMS/CIS Specialist | Digital & Social Media Marketer | Brand Promoter & Lead Generator

Ganesh Ariyur is a global enterprise technology executive and a Top 100 Digital Adoption Leader for 2025. He is known for delivering more than $500M in measurable enterprise value through large-scale digital transformation, enterprise systems modernization, cloud strategy, artificial intelligence adoption, data governance, & enterprise architecture leadership. His work spans more than 90 countries across Fortune 500 organizations, private-equity owned companies, and highly regulated industries. Ganesh serves as the Global Head of Enterprise Technology Strategy and Transformation at Gainwell Technologies, a $3B healthcare technology organization. He directs modernization programs across SAP S/4HANA, Oracle Cloud ERP, PeopleSoft, cloud platforms on AWS and Azure, enterprise applications, reporting and analytics, generative AI, intelligent automation, enterprise architecture, IT governance, and cybersecurity, aligned with operating models. His programs have delivered multi-million-dollar cost savings. He has directed enterprise portfolios valued at more than $1B. He has unified 450-plus legacy systems, led technology programs supporting more than $30B in M&A value, and guided organizations through complex TSA exits and carve-outs. Ganesh brings deep expertise in artificial intelligence-enabled operating models, multi-ERP modernization including SAP S/4 HANA, Oracle Cloud, & Workday, cloud strategy and FinOps, enterprise architecture, data, infrastructure, cybersecurity improvement, data quality & analytics modernization, robotic process automation & intelligent automation, shared services/global business services, organizational design, and long-term value creation. His people-process-technology approach led to his being named a Global Top 100 Digital Adoption Leader. He is a Certified AI Business Transformation Practitioner & a Certified Technology Innovation Practitioner. He is also a member of the Forbes Technology Council. He was publicly recognized for global transformation leadership when he was featured on billboards across Germany during a major enterprise program at Bayer. Ganesh is known for partnering with boards, CEOs, CFOs, & private equity operating teams. He aligns technology strategy with growth objectives, cost discipline, compliance needs, & long-term enterprise value. Based in Atlanta, he is regarded as a CIO leader who turns complexity into clarity and who consistently converts technology investment into measurable business outcomes.

I entered the hemp space at the very beginning when there were almost no guardrails, no industry playbook, and very few operators who truly understood what it took to formulate something that actually worked. Hemp-derived flower and hemp wellness products were barely a category. What existed was largely untested, poorly sourced, and built around novelty rather than need. From day one, our approach was different purpose before profit, formulation before marketing, and a deep belief that every formulation should serve a real purpose. At JustKana, I oversee product development, quality control, and sourcing from the ground up. That means building relationships directly with small-batch organic hemp farms, evaluating raw material quality before it ever reaches a formulation stage, and ensuring every finished product meets both our internal standards and third-party lab verification. My work lives at the intersection of plant science and consumer wellness. I specialize in cannabinoid formulation for real therapeutic outcomes sleep support, chronic pain relief, anxiety management, and inflammation using full-spectrum hemp extracts that preserve the natural compound profile of the plant rather than isolating single ingredients. Over the years I've helped develop products that have made a measurable difference for thousands of people veterans managing PTSD, seniors dealing with chronic joint pain, and individuals looking to replace pharmaceutical sleep aids with something cleaner and plant-derived. That direct connection to consumer outcomes shapes every formulation decision I make. I understand the hemp supply chain from soil to finished product cultivation practices, extraction methods, cannabinoid and terpene profiles, and how sourcing decisions downstream directly impact what a customer experiences. In a space flooded with white-labeled, mass-produced products, that depth of knowledge is rare.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Founder & CEO of Genbounty - AI safety & compliance testing. Genbounty is a an AI safety testing hub and provider of EU AI Act compliance and certification. About me AppSec SME, AI Engineer, Developer | BSc, MBA, PRINCE2, CompTIA+, CISSP

Drumil Joshi is a nationally recognized leader in AI-driven predictive analytics for renewable energy systems. With a Master of Science in Data Science from Indiana University Bloomington and a portfolio of 12 international research papers, 6 patents, and a published book, Drumil combines academic excellence with real-world operational impact. As the sole Monitoring & Diagnostics Analyst at Southern Power, he manages a $450M portfolio of solar, wind, and battery energy storage assets. He specializes in building end-to-end machine learning pipelines, real-time anomaly detection platforms, and operational stability indices that have enhanced renewable energy reliability and reduced manual analysis time by over 25 hours per week. Drumil’s innovative work—featuring cutting-edge tools like Azure Databricks, SHAP interpretability, and Dash visual analytics—has been nationally recognized by media outlets such as Hindustan Times, DNA India, TechBullion, and Silicon India. His mission is to democratize AI innovation for energy and industrial systems by providing tactical, scalable solutions that companies can implement without needing large teams. With a strong foundation in machine learning, energy analytics, automation, and sustainable AI systems, Drumil offers a unique blend of technical depth, entrepreneurial spirit, and thought leadership that continues to shape the future of smart energy management.

Rebecca Aba Gaisie is a recognized expert in sustainability and energy management, currently conducting high-impact research at Eastern Illinois University. She is the first-place recipient of the 2025 Award for Excellence in Student Research for her work on biodegradable packaging solutions for the beverage industry in developing markets. Her expertise spans Carbon Capture Deployment (CCS) in U.S. oil fields, the circular economy, and the strategic implementation of UN Sustainable Development Goals (SDGs). Rebecca’s work bridges the gap between technical energy transition strategies and practical business sustainability.

David Selakovic is the CEO and President of Vegalab SA, a Swiss biotech advancing natural solutions for global food systems. Under his leadership, Vegalab develops high-performance biologicals and specialty inputs that help growers boost yield and quality while shrinking chemical footprints and protecting pollinators. The company’s platforms—micronization, nano-encapsulation, and in-vivo cultivation of beneficial microorganisms—are engineered to match the efficacy and usability of synthetics, with sustainability built in from the start. Headquartered in Switzerland with a growing international footprint, Vegalab supports farmers, distributors, and innovators across regions with rapid product development and field-level support, and maintains a commitment to carbon-neutral operations and FSC-certified communications. Selakovic speaks frequently on scaling biologicals, translating lab breakthroughs to farm outcomes, and building resilient, zero-residue value chains.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Jason White is the CEO and majority owner of LEC Partners, a Cambridge, MA-based advisory firm that has helped clients navigate the bioeconomy for over 30 years. He works with investors, developers, and operators to evaluate technologies, structure projects, and reduce technical and commercial risk in areas such as renewable fuels, biomaterials, and low-carbon feedstocks. Jason’s background spans four continents and multiple industries, including fintech, medtech, and renewable energy. Before leading LEC Partners, he ran a fintech and consulting firm in Shenzhen, advised the founder of a medical device startup in Switzerland, and managed C-suite relationships with major retailers, banks, IT firms, and private equity investors. This mix of operating, deal-making, and cross-border experience gives Jason a practical perspective on how emerging technologies move from concept to bankable projects. Journalists often turn to him for clear explanations of complex topics such as project development risk, bioeconomy policy impacts, and how investors are underwriting new technologies in real deals. Jason is based in the Greater Boston area with his family, where he is raising two sons, coaching youth sports, and staying closely engaged with the next generation of problem-solvers.